ResMed Inc. Files 8-K on Security Holder Votes
Ticker: RSMDF · Form: 8-K · Filed: Nov 21, 2024 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.004 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: RMD
TL;DR
ResMed filed an 8-K for shareholder votes - details to follow.
AI Summary
ResMed Inc. filed an 8-K on November 20, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it serves as an official notification of such events.
Why It Matters
This filing indicates that ResMed Inc. has held or is holding a vote involving its shareholders, which could pertain to corporate governance, executive compensation, or other significant company decisions.
Risk Assessment
Risk Level: low — The filing is a procedural notification of a shareholder vote and does not disclose any immediate financial or operational risks.
Key Players & Entities
- ResMed Inc. (company) — Registrant
- November 20, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 9001 Spectrum Center Boulevard San Diego , California 92123 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of ResMed Inc.'s security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were presented.
When was the date of the earliest event reported in this 8-K?
The date of the earliest event reported is November 20, 2024.
What is ResMed Inc.'s state of incorporation?
ResMed Inc. is incorporated in Delaware.
What is the address of ResMed Inc.'s principal executive offices?
The principal executive offices are located at 9001 Spectrum Center Boulevard, San Diego, California 92123.
What is the SEC file number for ResMed Inc.?
The SEC file number for ResMed Inc. is 001-15317.
Filing Stats: 572 words · 2 min read · ~2 pages · Grade level 13.9 · Accepted 2024-11-21 17:20:32
Key Financial Figures
- $0.004 — ange on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
Filing Documents
- d868806d8k.htm (8-K) — 43KB
- 0001193125-24-263501.txt ( ) — 163KB
- rmd-20241120.xsd (EX-101.SCH) — 3KB
- rmd-20241120_lab.xml (EX-101.LAB) — 18KB
- rmd-20241120_pre.xml (EX-101.PRE) — 11KB
- d868806d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. RESMED INC. Date: November 21, 2024 By: /s/ Michael Rider Michael Rider Chief Legal Officer, Global General Counsel and Secretary